Dr. Saad Jamshed, MD

Dr. Jamshed practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Jamshed's NPI, 1659522662, was assigned on October 8, 2008. Dr. Jamshed holds New York license 251692-1.

Dr. Jamshed's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Jamshed's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Jamshed is also affiliated with Unity Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Jamshed to 2 more hospitals and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamshed practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Jamshed's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Jamshed is licensed in New York.

CMS data shows 310 Medicare services from Dr. Jamshed across 5 procedure codes in 2024, for 124 Medicare patients. Medicare paid $24,008 for them.

CMS counts 124 Medicare patients who saw Dr. Jamshed in 2024. The largest group is 65 to 74, with 47 patients. 74% of them have high blood pressure, and 73% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Jamshed's median patient age at 74, with 48% women.

In 2024, Dr. Jamshed wrote 433 Medicare Part D claims for 100 patients. 66% of them were for generic drugs. CMS names the drug for 327 of them, across 13 drugs with 11 or more claims each, at $1,071,555 in total drug cost. In 2023, CMS named 323 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Jamshed for performance year 2024, reported through an alternative payment model (APM). Dr. Jamshed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Jamshed, published from 2011 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Multiple Myeloma and Pneumococcal Vaccines. Dr. Jamshed has published most often in Cureus. Dr. Jamshed's most frequent co-authors are Mohammad Ammad Ud Din, MD, Jonathan Wade Bress, MD and Ali Mohammad Saleh Abdelhay, MD.

CMS Open Payments shows 112 general payments to Dr. Jamshed from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $44,790. It also lists 1 research payment totaling $2,679 in 2019.